ALDH1A3 and gastric cancer: To evaluate the effects of anticancer drugs on ALDH1A3 expression in a clinical context, we analyzed ALDH1A3 expression in FFPE tissues from 40 gastric cancers, including 20 cases treated with NAC with fluoropyrimidines and platinum agents and 20 treatment-naïve cases.